Alkermes Plc
NASDAQ:ALKS
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
23.01
32.56
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Alkermes Plc
Wall Street
Price Targets
ALKS Price Targets Summary
Alkermes Plc
According to Wall Street analysts, the average 1-year price target for
ALKS
is 34.76 USD
with a low forecast of 21.21 USD and a high forecast of 45.15 USD.
ALKS Last Price Targets
Alkermes Plc
The latest public price target was made on Nov 13, 2024 by
Vamil Divan
from
Mizuho Securities
,
who expects
ALKS
stock to
rise by 35%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Vamil Divan
Mizuho Securities
|
40
USD
Upside 35% |
1 month ago
Nov 13, 2024
|
Alkermes (ALKS) PT Raised to $40 at Mizuho
StreetInsider
|
Paul Matteis
Stifel Nicolaus
|
36
USD
Upside 21% |
1 month ago
Nov 4, 2024
|
Stifel Upgrades Alkermes (ALKS) to Buy
StreetInsider
|
|
Paul Matteis
Stifel Nicolaus
|
25
USD
Downside 16% |
1 month ago
Oct 24, 2024
|
Alkermes (ALKS) PT Lowered to $25 at Stifel
StreetInsider
|
|
Douglas Tsao
H.C. Wainwright
|
37
USD
Upside 25% |
2 months ago
Oct 14, 2024
|
H.C. Wainwright Reiterates Neutral Rating on Alkermes (ALKS)
StreetInsider
|
Akash Tewari
Jefferies
|
50
USD
Upside 68% |
8 months ago
Apr 10, 2024
|
Alkermes (ALKS) PT Raised to $50 at Jefferies
StreetInsider
|
|
Vamil Divan
Mizuho Securities
|
35
USD
Upside 18% |
8 months ago
Apr 9, 2024
|
Mizuho on Alkermes (ALKS): 'We maintain our Buy rating, believing that ALKS 2680 is underappreciated'
StreetInsider
|
|
Akash Tewari
Jefferies
|
25
USD
Downside 16% |
8 months ago
Apr 9, 2024
|
Alkermes price target raised to $50 at Jefferies after 'excellent' NT2 data
TheFly
|
Joel Beatty
Robert W. Baird
|
37
USD
Upside 25% |
9 months ago
Mar 18, 2024
|
Baird Starts Alkermes (ALKS) at Outperform
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ALKS's stock price target?
Price Target
34.76
USD
According to Wall Street analysts, the average 1-year price target for
ALKS
is 34.76 USD
with a low forecast of 21.21 USD and a high forecast of 45.15 USD.
What is Alkermes Plc's Revenue forecast?
Projected CAGR
-3%
For the last 8 years the
compound annual growth rate for
Alkermes Plc's revenue is
13%.
The projected
CAGR
for the next 4 years is
-3%.
What is Alkermes Plc's Operating Income forecast?
Projected CAGR
-8%
The
compound annual growth rate
of Alkermes Plc's operating income for the next 4 years is
-8%.
What is Alkermes Plc's Net Income forecast?
Projected CAGR
-4%
The
compound annual growth rate
of Alkermes Plc's net income for the next 4 years is
-4%.
You don't have any saved screeners yet
